Lisl Dunlop has over 30 years of experience providing antitrust support for her clients’ key strategic initiatives, including major transactions and agency investigations. Lisl guides clients through the antitrust-related aspects of mergers and acquisitions, joint ventures and other combinations, and agency investigations.

Lauded as a leading antitrust practitioner by international legal rankings, such as Chambers USA, The Legal 500 United States, and Crain’s New York Business, Lisl provides a global perspective to approaching antitrust aspects of transactions, litigation strategy, and government investigations. Having practiced in Australia, the UK, and the United States, she is adept at representing clients before the U.S. federal and state antitrust enforcement agencies, as well as international authorities.

Lisl represents clients in a broad range of industries – including the technology, media, and cannabis sectors – and has mounted a significant healthcare practice. She guides healthcare companies in addressing antitrust risk in transactions as well as a variety of other initiatives, such as accountable care organizations (ACOs), independent physician networks, and financial and clinical integration issues.

Lisl is a sought-after author and speaker on antitrust and competition law. Her many leadership roles include serving in the leadership of the New York State Bar Association Antitrust Law Section, American Health Lawyers Association’s Antitrust Practice Group, and the American Bar Association’s Antitrust Law Section. She dedicates her pro bono practice to assisting members of the LGBTQ+ community and indigent clients in immigration and asylum matters.